US-based medical device firm Rijuven has introduced CardioSleeve for paediatrics, the smart ECG stethoscope attachment that enhances cardio-diagnostic processes.
CardioSleeve is the first FDA cleared device that adds ECG capabilities to transform any existing stethoscope into a smart and mobile-connected device, offering three lead ECG, digital auscultation and real-time digital analysis for paediatric care.
Part of the company’s i2Dtx platform, CardioSleeve enables paediatricians and clinicians to accurately visualise heart sound, analyse for arrhythmia or murmur, and identify heart failure.
CardioSleeve provides advanced murmur detection analysis through synchronising digital heart sound with ECG, allowing the diagnosis of pathological and physiological heart sounds in patients as young as infants, at heart rates of up to 180 beats per minute.
The device captures digital acoustic and electric footprints of the heart and transmits them to a mobile device for real-time analysis, helping to create ejection fraction measurements for a systolic performance index, which is vital to identify heart failure.
Rijuven president Dr Raj Kapoor said: "With CardioSleeve and the i2Dtx platform, paediatricians now have the power of ECG right on the stethoscopes they already know and love.
"CardioSleeve makes existing stethoscopes smarter so they can do things an ordinary stethoscope can’t: visualise a heart murmur, quickly analyse heart rhythm, and identify heart failure, all while reducing costs and enhancing patient care."
i2Dtx is a portable and cloud-based medical device platform for heart, lung, vital signs, imaging and lab clinical assessments for any physical examination.
The platform comprises CardioSleeve and connected devices, including an otoscope, pulse ox, IR thermometer and blood pressure cuff.
Its optional additions include a weight scale, spirometer, ultrasound, and blood glucose monitor.
Image: Rijuven CardioSleeve for paediatrics. Photo: courtesy of BUSINESS WIRE / Rijuven.